404 related articles for article (PubMed ID: 17274600)
1. Evidence that the principal CoII-binding site in human serum albumin is not at the N-terminus: implication on the albumin cobalt binding test for detecting myocardial ischemia.
Mothes E; Faller P
Biochemistry; 2007 Feb; 46(8):2267-74. PubMed ID: 17274600
[TBL] [Abstract][Full Text] [Related]
2. Spectroscopic and thermodynamic determination of three distinct binding sites for Co(II) ions in human serum albumin.
Sokołowska M; Wszelaka-Rylik M; Poznański J; Bal W
J Inorg Biochem; 2009 Jul; 103(7):1005-13. PubMed ID: 19487034
[TBL] [Abstract][Full Text] [Related]
3. Albumin cobalt binding (ACB) test: its role as a novel marker of acute coronary syndrome.
Immanuel S; Sanjaya AI
Acta Med Indones; 2006; 38(2):92-6. PubMed ID: 16799211
[TBL] [Abstract][Full Text] [Related]
4. Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis.
Simard JR; Zunszain PA; Hamilton JA; Curry S
J Mol Biol; 2006 Aug; 361(2):336-51. PubMed ID: 16844140
[TBL] [Abstract][Full Text] [Related]
5. The cobalt-albumin binding assay: insights into its mode of action.
Bar-Or D; Rael LT; Bar-Or R; Slone DS; Mains CW; Rao NK; Curtis CG
Clin Chim Acta; 2008 Jan; 387(1-2):120-7. PubMed ID: 17964561
[TBL] [Abstract][Full Text] [Related]
6. Allosteric modulation of myristate and Mn(III)heme binding to human serum albumin. Optical and NMR spectroscopy characterization.
Fanali G; Fesce R; Agrati C; Ascenzi P; Fasano M
FEBS J; 2005 Sep; 272(18):4672-83. PubMed ID: 16156788
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the binding of oxovanadium(IV) to human serum albumin.
Correia I; Jakusch T; Cobbinna E; Mehtab S; Tomaz I; Nagy NV; Rockenbauer A; Pessoa JC; Kiss T
Dalton Trans; 2012 Jun; 41(21):6477-87. PubMed ID: 22476413
[TBL] [Abstract][Full Text] [Related]
8. Interaction of VO2+ ion with human serum transferrin and albumin.
Sanna D; Garribba E; Micera G
J Inorg Biochem; 2009 Apr; 103(4):648-55. PubMed ID: 19201482
[TBL] [Abstract][Full Text] [Related]
9. Effect of albumin conformation on the binding of ciprofloxacin to human serum albumin: a novel approach directly assigning binding site.
Ahmad B; Parveen S; Khan RH
Biomacromolecules; 2006 Apr; 7(4):1350-6. PubMed ID: 16602760
[TBL] [Abstract][Full Text] [Related]
10. Ibuprofen induces an allosteric conformational transition in the heme complex of human serum albumin with significant effects on heme ligation.
Nicoletti FP; Howes BD; Fittipaldi M; Fanali G; Fasano M; Ascenzi P; Smulevich G
J Am Chem Soc; 2008 Sep; 130(35):11677-88. PubMed ID: 18681435
[TBL] [Abstract][Full Text] [Related]
11. Allosteric and binding properties of Asp1-Glu382 truncated recombinant human serum albumin--an optical and NMR spectroscopic investigation.
Fanali G; Pariani G; Ascenzi P; Fasano M
FEBS J; 2009 Apr; 276(8):2241-50. PubMed ID: 19298387
[TBL] [Abstract][Full Text] [Related]
12. Determining molecular binding sites on human serum albumin by displacement of oleic acid.
Sarver RW; Gao H; Tian F
Anal Biochem; 2005 Dec; 347(2):297-302. PubMed ID: 16289007
[TBL] [Abstract][Full Text] [Related]
13. Copper transfer from Cu-Abeta to human serum albumin inhibits aggregation, radical production and reduces Abeta toxicity.
Perrone L; Mothes E; Vignes M; Mockel A; Figueroa C; Miquel MC; Maddelein ML; Faller P
Chembiochem; 2010 Jan; 11(1):110-8. PubMed ID: 19937895
[TBL] [Abstract][Full Text] [Related]
14. Insignificant role of the N-terminal cobalt-binding site of albumin in the assessment of acute coronary syndrome: discrepancy between the albumin cobalt-binding assay and N-terminal-targeted immunoassay.
Oh BJ; Seo MH; Kim HS
Biomarkers; 2012 Aug; 17(5):394-401. PubMed ID: 22630368
[TBL] [Abstract][Full Text] [Related]
15. [First experience with the cobalt binding capacity (ACB) test in the diagnosis of acute coronary syndrome (a pilot study)].
Stejskal D; Lacnák B; Juráková R; Adamovská S; Prosková J; Ochmanová R; Ozanová G
Vnitr Lek; 2004 Oct; 50(10):734-9. PubMed ID: 15633927
[TBL] [Abstract][Full Text] [Related]
16. New insights into the interactions of serum proteins with bis(maltolato)oxovanadium(IV): transport and biotransformation of insulin-enhancing vanadium pharmaceuticals.
Liboiron BD; Thompson KH; Hanson GR; Lam E; Aebischer N; Orvig C
J Am Chem Soc; 2005 Apr; 127(14):5104-15. PubMed ID: 15810845
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of oxidized human serum albumin. A slight structural change impairs its ligand-binding and antioxidant functions.
Kawakami A; Kubota K; Yamada N; Tagami U; Takehana K; Sonaka I; Suzuki E; Hirayama K
FEBS J; 2006 Jul; 273(14):3346-57. PubMed ID: 16857017
[TBL] [Abstract][Full Text] [Related]
18. Molecular dynamics study of conformational changes in human serum albumin by binding of fatty acids.
Fujiwara S; Amisaki T
Proteins; 2006 Aug; 64(3):730-9. PubMed ID: 16783783
[TBL] [Abstract][Full Text] [Related]
19. Correspondence of fatty acid and drug binding sites on human serum albumin: a two-dimensional nuclear magnetic resonance study.
Krenzel ES; Chen Z; Hamilton JA
Biochemistry; 2013 Mar; 52(9):1559-67. PubMed ID: 23360066
[TBL] [Abstract][Full Text] [Related]
20. Allosteric inhibition of cobalt binding to albumin by fatty acids: implications for the detection of myocardial ischemia.
Lu J; Stewart AJ; Sadler PJ; Pinheiro TJ; Blindauer CA
J Med Chem; 2012 May; 55(9):4425-30. PubMed ID: 22519414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
